Andrew Sinclair is of SOLENO THERAPEUTICS INC. Currently has a direct ownership of 6,500 shares of SLNO, which is worth approximately $375,570. The most recent transaction as insider was on Jun 06, 2024, when has been sold 6,500 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 6.5K
0% 3M change
n/a 12M change
Total Value Held $375,570

Andrew Sinclair Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 06 2024
BUY
Grant, award, or other acquisition
-
6,500 Added 50.0%
6,500 Common Stock

Also insider at

ACET
Adicet Bio, Inc. Healthcare
SRRA
Sierra Oncology, Inc. Healthcare
VRNA
Verona Pharma plc Healthcare
AS

Andrew Sinclair

Redwood City, CA

Track Institutional and Insider Activities on SLNO

Follow SOLENO THERAPEUTICS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SLNO shares.

Notify only if

Insider Trading

Get notified when an Soleno Therapeutics Inc insider buys or sells SLNO shares.

Notify only if

News

Receive news related to SOLENO THERAPEUTICS INC

Track Activities on SLNO